Stage 1 oral cavity cancer is characterized by small, localized tumors with high survival rates, often detected early through routine exams. Diagnosis involves oral exams, biopsies, and imaging to ...

Recent research suggests that blood tests may show markers of oral cancer. But a blood test isn’t enough to confirm an oral cancer diagnosis. A biopsy is the only way to confirm it. Blood tests for ...

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier—improving patient outcomes and saving lives. Currently, no oral cancer salivary diagnostics are ...

Oral cancer screening is now integral to a patient's routine follow-up, as well as new patient evaluations. Spurred by the rise in oral cancer cases, this examination must be performed more frequently ...

The most common type of oral cancer tends to spread quickly, but progression depends on several factors, including location. Early diagnosis and treatment are key. Oral cancer refers to cancer that ...

A University of Chicago spinout has raised $4 million in seed funding to develop a unique, saliva-based test for oral cancers. OrisDX's funding was led by Revere Partners and strategic investment from ...

Surgery for oral cancer aims to remove cancerous cells and a small margin of healthy tissue. The type and extent of cancer will determine the type of surgery doctors recommend. Oral cancer is a ...

KSL Beutner Laboratories (Beutner) has launched a blood test to detect an antigen linked with the autoimmune blistering disease mucous membrane pemphigoid (MMP), which often causes painful lesions in ...